DLA Piper is a global law firm with a presence in over 40 countries and more than 90 offices across Europe, the United States, and Asia, and is widely recognized as a leader in Life Sciences and Healthcare.

DLA Piper advises pharmaceutical and medical device groups, biotech and medtech companies, and investment funds (VC/PE) on strategic transactions and high‑stakes matters, including M&A, financings, licensing and collaborations, clinical development, IP strategy and protection, regulatory compliance, and commercialization across the full product lifecycle, through fully integrated, multidisciplinary teams.